Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)

NARecruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Post-Concussion SyndromeCOVID Long-HaulCOVID-19
Interventions
DEVICE

percutaneous electrical nerve-field stimulation, PENFS

A novel, FDA approved for commercial use, cleared device that delivers field stimulation with alternating frequencies to the external ear

DEVICE

percutaneous electrical nerve-field stimulation, PENFS (sham device)

A novel, FDA approved for commercial use, cleared device that delivers field stimulation with alternating frequencies to the external ear. The sham device will not deliver field stimulation to the ear.

DEVICE

percutaneous electrical nerve-field stimulation, PENFS (COVID active device)

A novel, FDA approved for commercial use, cleared device that delivers field stimulation with alternating frequencies to the external ear

Trial Locations (1)

92868

RECRUITING

CHOC Children's, Orange

Sponsors
All Listed Sponsors
collaborator

Innovative Health Solutions

INDUSTRY

lead

Children's Hospital of Orange County

OTHER